Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Starpharma reports positive results from VivaGel study
Based on these results and existing supporting data, the product is deemed suitable for continued development as a topical microbicide for the prevention of HIV and genital herpes
Based on these results and existing supporting data, the product is deemed suitable for continued development as a topical microbicide for the prevention of HIV and genital herpes
Michael DiCandilo, executive vice president and CFO of AmerisourceBergen, expands his responsibilities with the added position of COO for AmerisourceBergen Drug Corporation (ABDC) and continues to report directly
Based on the overall results received from the studies till now, the company has concluded that the properties of the lead molecule would not outperform the already commercialized
Vaser Lipo or LipoSelection uses ultrasonic waves to liquefy fat before removal, creating realistic curves and definition for those hard-to-fix spots. Dan Goldberger, Sound Surgical’s CEO, said: “In
The trial (REO 012) is an open-label, dose-escalating, non-randomized trial of Reolysin given intravenously with escalating doses of cyclophosphamide. A standard dose of Reolysin is administered intravenously over
Rajesh Shrotriya, chairman, president and CEO of Spectrum, said: “The sale of these non-core assets provides additional non-dilutive funding which will be used to further fund the advancement
With this acquisition, Enzo Life Sciences now has US operations in New York, Pennsylvania and California, and overseas facilities in Switzerland, the UK and Belgium, as well as
Warner Chilcott’s Dovonex is indicated for the topical treatment of psoriasis of the scalp. Hi-Tech will pay Warner Chilcott a portion of the profits from the sale of
Mr Beck joins Ardea Biosciences from Metabasis Therapeutics, which he co-founded in 1999 and where he served most recently as senior vice president of finance, CFO and treasurer.
Increasing the accrual period allowed decreasing the total number of patients in the study, without changing the required statistical analyses. As a result, the Ovature study will enroll